In a surprising move, Novo Nordisk CEO Lars Fruergaard Jorgensen steps down as the company faces significant market challenges and competition from Eli Lilly's Zepbound. With share prices plummeting, the board seeks new leadership to navigate the turbulent landscape.
Discover Warren Buffett's reflections on Berkshire Hathaway's achievements, CEO succession plans, tax payments, cash reserves, acquisitions, and special 60th anniversary book in his latest shareholder letter.
